Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.
CME Group Inc.
CMEFinancialsGenerated Aug 19, 2026, 11:15 PM UTC
CME (CME Group Inc.) analytical snapshot. Revenue grew +6.4% YoY to $6.52B. 5-year revenue CAGR +6.8%; 10y CAGR +6.8%. Net margin at 62.45% (expanding ▲). Market cap $17.79B at $266.94 per share. Trailing P/E 23.92, P/S 2.73, P/B 0.67. EV/Operating income ≈ 3.70 (EV $15.65B). Risk: Elevated. Macro: Risk-on · Supportive. Composite analytical score 23 (data confidence 81%). Descriptive analytics from public filings — not investment advice.
Free SEC analysis
— computed from SEC filings, free to readFilings & Ownership
Latest annual report (10-K) filed Feb 26, 2026. Latest quarterly report (10-Q) filed Jul 24, 2026. 13 recent 8-K material-event filings in the index.
- Latest annual report (10-K) filed Feb 26, 2026.
- Latest quarterly report (10-Q) filed Jul 24, 2026.
- 13 recent 8-K material-event filings in the index.
- Recent insider Form 4s: 0 buy vs 0 sell transactions.
- ~10,000+ recent 13F-HR filings reference CME Group Inc.; broad institutional reporting.
- Recent filers include MARK MORRIS ET AL, WINNOW WEALTH LLC, Walleye Trading LLC.
- 1 recent 13D activist/beneficial-ownership filings — potential catalyst.
- 19 recent 13G passive institutional ownership notices.
| Filer | Form | Filed |
|---|---|---|
| MARK MORRIS ET AL | 13F-HR | Feb 13, 2008 |
| WINNOW WEALTH LLC | 13F-HR | Aug 21, 2025 |
| Walleye Trading LLC | 13F-HR | Nov 6, 2007 |
| CTC Fund Management LLC | 13F-HR | May 15, 2012 |
| Capital Wealth Planning, LLC | 13F-HR | Aug 13, 2018 |
| Date | Form | Description |
|---|---|---|
| Aug 11, 2026 | 8-K | 8-K |
| Jul 22, 2026 | 8-K | 8-K |
| Jun 17, 2026 | 8-K | 8-K |
| Jun 10, 2026 | 8-K | 8-K |
| May 19, 2026 | 8-K | 8-K |
| Apr 27, 2026 | 8-K | 8-K |
| Apr 22, 2026 | 8-K | 8-K |
| Feb 4, 2026 | 8-K | 8-K |
SEC Filing Deep-Analysis
1 risk signal(s), 1 positive signal(s), 1 watch item(s) detected from XBRL filing diff analysis. 1 positive signal(s) versus 1 risk signal(s). The filing exhibits more constructive indicators than concerns, though individual risk factors should still be monitored.
- Restatement of financial statements: The term "restatement of" "previously issued" appears in 1 recent filing(s) (vs 1 in the prior period). This risk language is ongoing.
- Deferred revenue growing — future revenue visibility: Deferred revenue grew +259.2% to $17.6M, providing forward revenue visibility. This is a positive leading indicator for subscription or contract-based businesses.
- NEW: Impairment charge: Impairment charge appears in recent filings but not in the prior 24-month period. Monitor for materiality.
- Endogenous analysis: 1 positive signal(s) versus 1 risk signal(s). The filing exhibits more constructive indicators than concerns, though individual risk factors should still be monitored.
- 20 new XBRL disclosure(s) in latest filing — expanding reporting scope.
- 20 disclosure(s) dropped from prior year — reduced reporting granularity.
- 1 new risk-language term(s) detected in filing text: Impairment charge.
- Ongoing high-severity risk language: Restatement of financial statements.
| Metric | Prior year | Latest year | Change | % Change |
|---|---|---|---|---|
| Revenue | $6.13B | $6.52B | $390.5M | +6.4% |
| Operating income | $3.93B | $4.23B | $298.0M | +7.6% |
| Net income | $3.53B | $4.07B | $546.4M | +15.5% |
| Operating cash flow | $3.69B | $4.28B | $586.6M | +15.9% |
| Capex | $94.0M | $83.5M | $-10.5M | -11.2% |
| Total assets | $137.45B | $198.42B | $60.98B | +44.4% |
| Total liabilities | $110.96B | $169.70B | $58.74B | +52.9% |
| Cash & equivalents | $2.89B | $4.42B | $1.52B | +52.7% |
| Stockholders equity | $26.49B | $28.73B | $2.24B | +8.5% |
| Accounts receivable | $573.1M | $639.2M | $66.1M | +11.5% |
| Type | Concepts |
|---|---|
| Added | AssetsFairValueDisclosure, ConversionOfStockSharesConverted1, ConvertiblePreferredStockSharesIssuedUponConversion, DividendsCash, EquitySecuritiesWithoutReadilyDeterminableFairValueAmount, EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount, FinanceLeaseLiabilityUndiscountedExcessAmount, FiniteLivedIntangibleAssetsAccumulatedAmortization, FiniteLivedIntangibleAssetsGross, IncrementalCommonSharesAttributableToConversionOfPreferredStock |
| Removed | AllocatedShareBasedCompensationExpense, AllowanceForDoubtfulAccountsReceivable, CommonStockDividendsPerShareDeclared, CurrentFederalTaxExpenseBenefit, CurrentForeignTaxExpenseBenefit, CurrentIncomeTaxExpenseBenefit, CurrentStateAndLocalTaxExpenseBenefit, DeferredFederalIncomeTaxExpenseBenefit, DeferredForeignIncomeTaxExpenseBenefit, DeferredStateAndLocalIncomeTaxExpenseBenefit |
| Term | Severity | Recent | Prior | Status |
|---|---|---|---|---|
| Restatement of financial statements | high | 1 | 1 | Ongoing |
| Impairment charge | medium | 5 | 0 | NEW |
| Restructuring | medium | 5 | 3 | Ongoing |
| Off-balance sheet arrangements | medium | 5 | 6 | Ongoing |
| Related party transactions | low | 5 | 0 | NEW |
Fundamentals
Revenue grew +6.4% YoY to $6.52B. 5-year revenue CAGR +6.8%; 10y CAGR +6.8%. Net margin at 62.45% (expanding ▲).
- Revenue grew +6.4% YoY to $6.52B.
- 5-year revenue CAGR +6.8%; 10y CAGR +6.8%.
- Net margin at 62.45% (expanding ▲).
- Return on equity 14.17%, ROA 2.05%, ROIC 14.72%.
- Gross margin 0.00%, operating margin 64.86%.
- Free cash flow margin 64.31% ($4.19B).
- Net income up ▲ +15.5% YoY.
- Asset turnover 0.03 — capital efficiency.
| FY | Revenue | Rev YoY | Gross% | Op% | Net% | FCF | ROE% |
|---|---|---|---|---|---|---|---|
| 2024 | $6.13B | +9.9% | 0.00 | 64.13 | 57.52 | $3.60B | 13.31 |
| 2025 | $6.52B | +6.4% | 0.00 | 64.86 | 62.45 | $4.19B | 14.17 |
| Quarter end | Revenue | YoY | QoQ | Net margin |
|---|---|---|---|---|
| Sep 30, 2024 | $1.58B | +18.4% | — | — |
| Mar 31, 2025 | $1.64B | +10.4% | +3.7% | — |
| Jun 30, 2025 | $1.69B | +10.4% | +3.0% | 60.59% |
| Sep 30, 2025 | $1.54B | -3.0% | -9.1% | — |
| Mar 31, 2026 | $1.88B | +14.5% | +22.3% | — |
| Jun 30, 2026 | $1.71B | +0.8% | -9.2% | 61.06% |
Pro analysis — preview
— score, signals & key metrics shown; full reasoning lockedValuation
Market cap $17.79B at $266.94 per share. Trailing P/E 23.92, P/S 2.73, P/B 0.67. EV/Operating income ≈ 3.70 (EV $15.65B).
- Market cap $17.79B at $266.94 per share.
Price & Technicals
Price $266.94 — downtrend (below 200-DMA); 1-month momentum positive. RSI(14) 49.59.
- Price $266.94 — downtrend (below 200-DMA); 1-month momentum positive.
Macro & Rates
Risk-on · Supportive. Real GDP growth 1.50% (quarterly, as of Apr 1, 2026). CPI inflation +3.3% YoY. Fed funds rate 3.63%, 10Y Treasury 4.71%.
- Market regime: Risk-on · Supportive.
Risk Scorecard
Composite risk Elevated. Liquidity current ratio 1.02 (adequate). Earnings stability: net-margin stdev 18.94pp over 19y.
- Composite risk: Elevated.
See the full picture behind every stock
Unlock the complete 10-year fundamentals, DCF & Graham intrinsic value, 13F/13D ownership flow, risk scorecard, multi-analyst bull/bear debate — plus watchlist alerts and your research workspace. Start with a 14-day Pro trial.
3 sections free · 4 Pro previews · composite 23
Macro exposure
Rate-sensitive · High sensitivityMacro regime: Risk-on · Supportive. CME Group Inc. is a rate-sensitive name (high macro sensitivity) — a supportive backdrop, though defensives lag risk-on tapes.
Analytical read
deterministic previewRevenue grew **+6.4%** YoY to $6.52B..
Peer comparison
Rate-sensitive groupHow CME stacks up against tracked peers with similar macro sensitivity — by analytical score and macro exposure.
| Company | Score | Macro |
|---|---|---|
| Allstate Corp. ALL | 30 | Neutral |
| Visa Inc. V | 24 | Neutral |
| CME Group Inc. CME● you | 23 | Neutral |
| Capital One Financial COF | 21 | Neutral |
| Charles Schwab Corp. SCHW | 19 | Neutral |
| American Express Co. AXP | 16 | Neutral |
| Simon Property Group SPG | 15 | Neutral |
| Digital Realty Trust DLR | 13 | Neutral |
| Mastercard Inc. MA | 11 | Neutral |
| U.S. Bancorp USB | 10 | Neutral |
| Travelers Cos. TRV | 10 | Neutral |
| Chubb Ltd. CB | 7 | Neutral |
| MetLife Inc. MET | 7 | Neutral |
| JPMorgan Chase & Co. JPM | 7 | Neutral |
| Welltower Inc. WELL | 6 | Neutral |
| Dominion Energy D | 4 | Neutral |
| Bank of America Corp. BAC | 3 | Neutral |
| Moody's Corp. MCO | 2 | Neutral |
| PNC Financial Services PNC | 2 | Neutral |
| Wells Fargo & Co. WFC | 1 | Neutral |
| BlackRock Inc. BLK | 1 | Neutral |
| American Tower Corp. AMT | 0 | Neutral |
| American Electric Power AEP | 0 | Neutral |
| Bank of New York Mellon BK | 0 | Neutral |
| Marsh & McLennan MMC | 0 | Neutral |
| Truist Financial TFC | -1 | Neutral |
| American Water Works AWK | -2 | Neutral |
| Equinix Inc. EQIX | -4 | Neutral |
| Goldman Sachs Group GS | -4 | Neutral |
| Prologis Inc. PLD | -5 | Neutral |
| Xcel Energy XEL | -5 | Neutral |
| Public Storage PSA | -5 | Neutral |
| Citigroup Inc. C | -5 | Neutral |
| Realty Income Corp. O | -6 | Neutral |
| Equity Residential EQR | -10 | Neutral |
| NextEra Energy NEE | -13 | Neutral |
| Duke Energy Corp. DUK | -14 | Neutral |
| Southern Company SO | -14 | Neutral |
| Exelon Corp. EXC | -14 | Neutral |
| Morgan Stanley MS | -14 | Neutral |
| S&P Global SPGI | -19 | Neutral |
| Crown Castle Inc. CCI | -21 | Neutral |
| American International Group AIG | -23 | Neutral |